Literature DB >> 2826545

Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

V Sundaresan1, I C Forgacs, D G Wight, B Wilson, G I Evan, J V Watson.   

Abstract

Monoclonal antibodies raised by synthetic peptide immunisation were used to determine the distribution of the protein product of the c-myc gene by immunocytochemical staining of archival wax embedded material from patients with familial adenomatous polyposis. Polyps from 18 cases of familial adenomatous polyposis, 10 of whom had developed malignant change, and 30 normal control colonic biopsy specimens were examined. A consistent staining pattern was observed in normal mucosa; nuclear staining in the basal proliferative zone; mixed nuclear and cytoplasmic staining in the maturation zone; and cytoplasmic localisation in the surface mature zone. In contrast, the polyps and carcinomata showed a mixed pattern of cytoplasmic and nuclear localisation in the basal proliferative zone with nuclear persistence throughout the crypts to the surface mature zone. This abnormal distribution of the c-myc oncogene product may have a role in the evolution of polyps and their subsequent malignant transformation into familial adenomatous polyposis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826545      PMCID: PMC1141224          DOI: 10.1136/jcp.40.11.1274

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  43 in total

1.  Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins.

Authors:  G I Evan; D C Hancock
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

2.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

Authors:  C J Sherr; C W Rettenmier; R Sacca; M F Roussel; A T Look; E R Stanley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

3.  A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.

Authors:  J V Watson; K Sikora; G I Evan
Journal:  J Immunol Methods       Date:  1985-10-24       Impact factor: 2.303

4.  Cell-type-specific pattern of myc protooncogene expression in developing human embryos.

Authors:  S Pfeifer-Ohlsson; J Rydnert; A S Goustin; E Larsson; C Betsholtz; R Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

5.  Calcification of entheses associated with X-linked hypophosphatemic osteomalacia.

Authors:  R P Polisson; S Martinez; M Khoury; R M Harrell; K W Lyles; N Friedman; J M Harrelson; E Reisner; M K Drezner
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

6.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

7.  c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells.

Authors:  S R Hann; C B Thompson; R N Eisenman
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

8.  Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.

Authors:  P H Rabbitts; J V Watson; A Lamond; A Forster; M A Stinson; G Evan; W Fischer; E Atherton; R Sheppard; T H Rabbitts
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

9.  Detection of the c-myc oncogene product in testicular cancer.

Authors:  K Sikora; G Evan; J Stewart; J V Watson
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

10.  Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.

Authors:  P Hendy-Ibbs; H Cox; G I Evan; J V Watson
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

View more
  9 in total

1.  Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis.

Authors:  A J Macpherson; K A Chester; L Robson; I Bjarnason; A D Malcolm; T J Peters
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 2.  Oncogenes and gastrointestinal cancer.

Authors:  I Forgacs
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  The role of oncogenes in gastrointestinal cancer.

Authors:  Emmanouil P Pappou; Nita Ahuja
Journal:  Gastrointest Cancer Res       Date:  2010-11

Review 4.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

5.  Dual regulation of Myc by Abl.

Authors:  V J Sanchez-Arévalo Lobo; M Doni; A Verrecchia; S Sanulli; G Fagà; A Piontini; M Bianchi; M Conacci-Sorrell; G Mazzarol; V Peg; J H Losa; P Ronchi; M Ponzoni; R N Eisenman; C Doglioni; B Amati
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

6.  c-myc protein distribution. Neoplastic tissues of the human colon.

Authors:  N Tulchin; L Ornstein; N Harpaz; J Guillem; C Borner; K O'Toole
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

7.  C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy.

Authors:  S V Polacarz; N A Hey; T J Stephenson; A S Hill
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

8.  C-myc oncogene expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; K Rogers; F Sharp; J H Smith; S V Polacarz
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

9.  Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.

Authors:  J Blancato; B Singh; A Liu; D J Liao; R B Dickson
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.